La cadena de opciones muestra datos clave de las opciones de acciones de CureVac a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para CureVac..

CureVac (NASDAQ:CVAC) Bolsa, Cadena de Opciones

CureVac

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

Large Cap

News

Health Care

General

CVAC

MRNA

NVAX

Un trabajador lechero en Nevada da positivo en gripe aviar H5N1. CDC investiga mientras la cepa se propaga en aves y ganado.

Gripe aviar en EE.UU.: trabajador lechero en Nevada da positivo

CureVac NV

Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) released its first-quarter results after Wednesday's closing bell. Here's a look at the key figures from the quarter. 
The Details:  Luminar Technologies reported quarterly losses of $1.50 per share, which beat the analyst consensus estimate of losses of $1.78. Quarterly revenue came in at $18.89 million, which beat the Street estimate of $15.98 million.
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/05/45414265/nvidia-climbs-on-saudi-ai-investments-analyst-estimates-15-billion-to-20-billion-in-revenue?utm_source=articleShare">Nvidia Climbs On Saudi AI Investments: Analyst Estimates $15 Billion To $20 Billion In Revenue&nbsp;</a>
Luminar announced a new operating plan enabled by a unified product architecture. The company expects it will reduce quarterly non-GAAP opreational expenditures by approximately half by the end of fiscal 2025 versus the beginning of fiscal 2024.
&#8220;In a world of macro uncertainty and adversity, we&#8217;re firing on all cylinders to ramp up production, ramp down costs and capitalize on the future, as evidenced by our announcements today,&#8221; said CEO Austin Russell.
&#8220;This kicks off our new operating plan for Luminar with a unified product platform, enabling radical focus and streamlining of the business, as well as unlocking value throughout our organization.&#8221;
LAZR Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Luminar Technologies stock was down 1.68% at $4.68 after-hours on Wednesday.  
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45353123/quantum-stocks-are-hot-in-2025-biggest-movers-to-watch?utm_source=articleShare">Quantum Stocks Are Hot In 2025: Biggest Movers To Watch&nbsp;</a></li>
</ul>
Image: Shutterstock

Earnings

Movers

Tech

LAZR

Luminar Technologies Shares Slip After Q1 Results, New Operating Plan

Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) lowers FY2025 sales outlook from $29.00 million-$32.00 million to $26.00 million-$30.00 million vs $33.43 million estimate.

Guidance

BNGO

Bionano Genomics Lowers FY2025 Sales Guidance from $29.00M-$32.00M to $26.00M-$30.00M vs $33.43M Est

Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) sees Q2 sales of $6.300 million-$6.800 million vs $7.02 million analyst estimate.

Bionano Genomics Sees Q2 Sales $6.300M-$6.800M vs $7.02M Est

WIIM

Dick's Sporting Goods shares are trading lower after WSJ reported the company is near a deal to buy Foot Locker.

Foot Locker shares are trading higher after WSJ reported Dick's Sporting Goods nears deal to buy the company.

<a href="https://www.wsj.com/business/deals/dicks-sporting-goods-nears-deal-to-buy-foot-locker-7ecf9194?msockid=21c662101c496b42343370ae1de86aaa">https://www.wsj.com/business/deals/dicks-sporting-goods-nears-deal-to-buy-foot-locker-7ecf9194?msockid=21c662101c496b42343370ae1de86aaa</a>

'Dick's Sporting Goods Nears Deal to Buy Foot Locker'- Wall Street Journal

Acquisition Adds Patented Water Treatment Technology with Expected Broad Cross- Platform Applications; Increases Shareholder Equity Through Preferred Stock Structure
Transaction Strengthens Edible Garden's Balance Sheet with $3 Million of Cash Through Private Placement
Intended to Enhance Vertically Integrated Model and Advance Zero-Waste Inspired&#xAE; Mission in High-Growth, Sustainable Agriculture Sector
Strengthens Edible Garden's Leadership in Sustainability and Controlled Environment Agriculture
BELVIDERE, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced the acquisition of certain assets of a sustainable aquaculture company based in Fort Dodge, Iowa, from NaturalShrimp Farms Inc. ("NaturalShrimp"). Edible Garden purchased the NaturalShrimp assets in exchange for $12 million of a new class of the Company's preferred stock. In addition, an affiliate of NaturalShrimp, agreed to purchase $3.5 million of the Company's preferred stock for cash, of which $3 million is being funded immediately, bringing its total investment in the Company's preferred stock to $15.5 million. As part of the acquisition, Edible Garden will gain two innovative patents for environmentally friendly water treatment technologies, along with a fully operational shrimp farming facility.
The acquisition is expected to support multiple strategic initiatives at Edible Garden, including expanded R&amp;D and warehousing. The Company intends to integrate the patented water treatment technology across its existing CEA operations, opening new possibilities for improving agricultural efficiency and sustainability. This development aligns with Edible Garden's Zero-Waste Inspired&#xAE; mission and enhances the Company's vertically integrated model.

EDBL

Edible Garden Acquires Patented Water Treatment Technology And Operational Shrimp Facility From NaturalShrimp In $15.5M Preferred Stock Deal, Adding $3M In Cash, Enhancing Balance Sheet, Advancing Zero-Waste Inspired Mission, And Expanding Cross-Platform Applications In Sustainable Agriculture

Integra Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITRG#AMEX">ITRG</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.08 by 62.5 percent. This is a 137.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported $57.02 million in sales this quarter.

Earnings Misses

ITRG

Integra Resources Q1 Adj. EPS $0.03 Misses $0.08 Estimate, Sales $57.02M

IPDN

Professional Diversity Q1 EPS $(0.39) Up From $(0.70) YoY, Sales $1.50M Down From $1.73M YoY

Sadot Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDOT#NASDAQ">SDOT</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.20 by 20 percent. This is a 20 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $132.17 million which missed the analyst consensus estimate of $145.70 million by 9.29 percent. This is a 24.09 percent increase over sales of $106.51 million the same period last year.

SDOT

Sadot Group Q1 EPS $0.16 Misses $0.20 Estimate, Sales $132.17M Miss $145.70M Estimate

Tungray Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) reported quarterly losses of $(0.03) per share. This is a 150 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $12.81 million in sales this quarter. This is a 10.81 percent decrease over sales of $14.36 million the same period last year.

TRSG

Tungray Technologies FY EPS $(0.03) Down From $0.06 YoY, Sales $12.81M Down From $14.36M YoY

Africa Oil (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AOI#TSX">AOI</a>) reported quarterly earnings of $0.11 per share. This is a 1000 percent increase over earnings of $0.01 per share from the same period last year. The company reported $76.40 million in sales this quarter.

TSX:AOI

Africa Oil Q1 EPS $0.11 Up From $0.01 YoY, Sales $76.40M

Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) released its fourth-quarter results after Wednesday's closing bell. Here's a look at the details<a href="https://www.benzinga.com/pressreleases/25/05/b45420117/boot-barn-holdings-inc-announces-fourth-quarter-and-fiscal-year-2025-financial-results-and-200-mil"> from the report. </a>
The Details: Boot Barn reported quarterly earnings of $1.22 per share, which missed the analyst consensus estimate of $1.24. Quarterly revenue of $453.75 million missed the Street estimate of $458.42 million.
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/05/45414265/nvidia-climbs-on-saudi-ai-investments-analyst-estimates-15-billion-to-20-billion-in-revenue?utm_source=articleShare">Nvidia Climbs On Saudi AI Investments: Analyst Estimates $15 Billion To $20 Billion In Revenue&nbsp;</a>
Boot Barn&#8217;s board of directors authorized the company to repurchase up to $200 million of its common stock.
&#8220;Our team delivered a solid finish to fiscal year 2025 highlighted by 15% annual total sales growth and 23% growth in earnings per diluted share, underscoring the ongoing resilience of our core consumer despite broader market uncertainties. The continued strength across major merchandise categories, channels, and geographies reaffirms the broad appeal of our brand and the effectiveness of our strategic initiatives,&#8221; commented CEO John Hazen. &nbsp;
Outlook:&nbsp;Boot Barn expects first-quarter EPS of between $1.44 and $1.52, versus the $1.44&nbsp;analyst estimate, and revenue in a range of&nbsp;$483 million to $491 million, versus the $486.49 million&nbsp;estimate.
Boot Barn sees fiscal 2026 GAAP earnings of between&nbsp;$5.50 and $6.40&nbsp;per share, versus the $6.24&nbsp;analyst estimate, and revenue in a range of&nbsp;$2.07 billion to $2.15 billion, versus the&nbsp;$2.17 billion&nbsp;estimate.
BOOT Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Boot Barn stock was up 16.31% at $154.50 after-hours Wednesday.  
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45353123/quantum-stocks-are-hot-in-2025-biggest-movers-to-watch?utm_source=articleShare">Quantum Stocks Are Hot In 2025: Biggest Movers To Watch&nbsp;</a></li>
</ul>
Photo: Shutterstock

Buybacks

After-Hours Center

BOOT

Boot Barn Stock Steps Higher Despite Q4 Miss: Here's Why

Stantec (TSX:<a class="ticker" href="https://www.benzinga.com/stock/STN#TSX">STN</a>) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.10 by 5.45 percent. This is a 28.89 percent increase over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $1.55 billion which beat the analyst consensus estimate of $1.54 billion by 0.84 percent. This is a 13.36 percent increase over sales of $1.37 billion the same period last year.

Earnings Beats

TSX:STN

Stantec Q1 Adj. EPS $1.16 Beats $1.10 Estimate, Sales $1.55B Beat $1.54B Estimate

AutoCanada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ACQ#TSX">ACQ</a>) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.02 by 1750 percent. This is a 8.82 percent increase over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $1.24 billion which beat the analyst consensus estimate of $1.17 billion by 5.98 percent. This is a 12.74 percent decrease over sales of $1.42 billion the same period last year.

TSX:ACQ

AutoCanada Q1 GAAP EPS $0.37 Beats $0.02 Estimate, Sales $1.24B Beat $1.17B Estimate

GCTK

GlucoTrack Q1 EPS $(0.67) Up From $(11.73) YoY

Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) has outperformed the market over the past 20 years by 3.28% on an annualized basis producing an average annual return of 11.56%. Currently, Micron Technology has a market capitalization of $106.65 billion. 
Buying $1000 In MU: If an investor had bought $1000 of MU stock 20 years ago, it would be worth $9,043.64 today based on a price of $95.43 for MU at the time of writing.
<h3>Micron Technology's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747257316_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Bird Construction (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BDT#TSX">BDT</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.18 by 27.78 percent. This is a 15 percent increase over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $717.55 million which missed the analyst consensus estimate of $742.56 million by 3.37 percent. This is a 4.27 percent increase over sales of $688.20 million the same period last year.

TSX:BDT

Bird Construction Q1 Adj. EPS $0.23 Beats $0.18 Estimate, Sales $717.55M Miss $742.56M Estimate

CleanCore Solutions (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#AMEX">ZONE</a>) reported quarterly losses of $(0.10) per share. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year. The company reported $557.91 thousand in sales this quarter. This is a 77.73 percent increase over sales of $313.92 thousand the same period last year.

ZONE

CleanCore Solutions Q3 EPS $(0.10) Up From $(0.11) YoY, Sales $557.91K Up From $313.92K YoY

Ceres Global Ag (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CRP#TSX">CRP</a>) reported quarterly earnings of $0.05 per share. This is a 66.67 percent increase over earnings of $0.03 per share from the same period last year. The company reported $214.98 million in sales this quarter. This is a 1.25 percent increase over sales of $212.32 million the same period last year.

TSX:CRP

Ceres Global Ag Q3 Adj. EPS $0.05 Up From $0.03 YoY, Sales $214.98M Up From $212.32M YoY

Events

Press Releases

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

CureVac to Present at the 12th International mRNA Health Conference

Management

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World's Top Innovators

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer

Comments

CureVac

CureVac (CVAC) Opciones

CureVac (NASDAQ:CVAC) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL